Nitisinone desensitization protocol, case report of hereditary Tyrosinemia type 1 with successful treatment and outcomes. [PDF]
Vallejo M +6 more
europepmc +1 more source
A Comprehensive In Vitro and In Silico Approach for Targeting 4-Hydroxyphenyl Pyruvate Dioxygenase: Towards New Therapeutics for Alkaptonuria. [PDF]
Bernardini G +8 more
europepmc +1 more source
Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase. [PDF]
Bai L +9 more
europepmc +1 more source
Overview of European Practices for Management of Tyrosinemia Type 1: Towards European Guidelines. [PDF]
Kuypers AM +5 more
europepmc +1 more source
Anthropometric, Body Composition, and Nutritional Indicators with and without Nutritional Intervention during Nitisinone Therapy in Alkaptonuria. [PDF]
Ranganath LR +11 more
europepmc +1 more source
TolCV1 inhibition by NPPB renders <i>Vibrio vulnificus</i> less virulent and more susceptible to antibiotics. [PDF]
Gong Y +7 more
europepmc +1 more source
Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1. [PDF]
Ates I +13 more
europepmc +1 more source
Degradation Pathways of 2- and 4-Nitrobenzoates in Cupriavidus sp. Strain ST-14 and Construction of a Recombinant Strain, ST-14::3NBA, Capable of Degrading 3-Nitrobenzoate. [PDF]
Basu S +3 more
europepmc +1 more source
Antifungal activity against Candida albicans of methyl 3,5-dinitrobenzoate loaded nanoemulsion. [PDF]
Duarte ABS +6 more
europepmc +1 more source
New Insights into the <i>In Situ</i> Fenton-like Process by Copper(II)-hydroxylamine Coupling: Reactive Species, Applications, and Limitations. [PDF]
Pellegrino S +8 more
europepmc +1 more source

